{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Adult+Congenital+Heart+Disease&page=4", "query": { "condition": "Adult Congenital Heart Disease", "page": 4 }, "page_size": 10 }, "pagination": { "page": 4, "page_size": 10, "total_count": 100, "total_pages": 10, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Adult+Congenital+Heart+Disease&page=5&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Adult+Congenital+Heart+Disease&page=3&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-12T15:50:00.955Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05737485", "title": "Study Evaluating the Safety and Tolerability of RCT1100 in Healthy and PCD Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Primary Ciliary Dyskinesia" ], "interventions": [ { "name": "RCT1100", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "ReCode Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 9, "start_date": "2023-02-18", "completion_date": "2025-01-13", "has_results": false, "last_update_posted_date": "2025-04-29", "last_synced_at": "2026-10-12T15:50:00.955Z", "location_count": 1, "location_summary": "Las Vegas, Nevada", "locations": [ { "city": "Las Vegas", "state": "Nevada" } ], "official_url": "https://clinicaltrials.gov/study/NCT05737485" }, { "nct_id": "NCT03701399", "title": "Troriluzole in Adult Participants With Spinocerebellar Ataxia", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Spinocerebellar Ataxias", "Spinocerebellar Ataxia Type 1", "Spinocerebellar Ataxia Type 2", "Spinocerebellar Ataxia Type 3", "Spinocerebellar Ataxia Type 6", "Spinocerebellar Ataxia Type 7", "Spinocerebellar Ataxia Type 8", "Spinocerebellar Ataxia Type 10" ], "interventions": [ { "name": "troriluzole", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Biohaven Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 299, "start_date": "2019-03-08", "completion_date": "2026-08", "has_results": true, "last_update_posted_date": "2026-06-24", "last_synced_at": "2026-10-12T15:50:00.955Z", "location_count": 21, "location_summary": "Phoenix, Arizona • Long Beach, California • Los Angeles, California + 16 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Long Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Aurora", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT03701399" }, { "nct_id": "NCT02441829", "title": "Pharmacokinetics of Eleclazine in Adults With Normal and Impaired Renal Function", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Long QT Syndrome" ], "interventions": [ { "name": "Eleclazine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Gilead Sciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 55, "start_date": "2015-05", "completion_date": "2015-12", "has_results": false, "last_update_posted_date": "2015-12-22", "last_synced_at": "2026-10-12T15:50:00.955Z", "location_count": 5, "location_summary": "DeLand, Florida • Miami, Florida • Orlando, Florida + 2 more", "locations": [ { "city": "DeLand", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Orlando", "state": "Florida" }, { "city": "Saint Paul", "state": "Minnesota" }, { "city": "Kansas City", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT02441829" }, { "nct_id": "NCT04141891", "title": "Advancing Understanding of Transportation Options", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Diabetic Retinopathy", "Macular Degeneration", "Glaucoma", "Retinitis Pigmentosa", "Vision Disorders", "Acute Coronary Syndrome", "Implantable Defibrillator User", "Congestive Heart Failure", "Hypertrophic Obstructive Cardiomyopathy", "Orthostatic Hypotension", "Syncope", "Presyncope", "Narcolepsy", "Dementia", "Multiple Sclerosis", "Parkinson Disease", "Brain Injuries", "Spinal Cord Injuries", "Stroke", "Vertigo", "Dizziness", "Seizures", "Substance Use", "Insulin Dependent Diabetes Mellitus", "Arthritis", "Foot--Abnormalities", "Chronic Obstructive Pulmonary Disease", "Obstructive Sleep Apnea", "End Stage Renal Disease", "Sleep Apnea", "Insomnia", "Restless Legs Syndrome" ], "interventions": [ { "name": "Driving Decision Aid", "type": "BEHAVIORAL" }, { "name": "Older Drivers Website", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Colorado, Denver", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 529, "start_date": "2019-12-12", "completion_date": "2023-12-21", "has_results": true, "last_update_posted_date": "2025-02-21", "last_synced_at": "2026-10-12T15:50:00.955Z", "location_count": 3, "location_summary": "La Jolla, California • Aurora, Colorado • Indianapolis, Indiana", "locations": [ { "city": "La Jolla", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Indianapolis", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT04141891" }, { "nct_id": "NCT06693674", "title": "Effect of Sacubitril-Valsartan on Cardiac Structure and Function", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Congenital Heart Disease" ], "interventions": [ { "name": "Entresto Pill", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 45, "start_date": "2025-02-03", "completion_date": "2028-08", "has_results": false, "last_update_posted_date": "2026-10-09", "last_synced_at": "2026-10-12T15:50:00.955Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT06693674" }, { "nct_id": "NCT07426419", "title": "An AAV Gene Therapy Trial of AFTX-201 in Adults With BAG3-Associated Dilated Cardiomyopathy (DCM)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Dilated Cardiomyopathy (DCM)", "BAG3 Mutation Associated Dilated Cardiomyopathy" ], "interventions": [ { "name": "AFTX-201", "type": "GENETIC" } ], "intervention_types": [ "GENETIC" ], "sponsor": "Affinia Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 22, "start_date": "2026-09", "completion_date": "2032-12", "has_results": false, "last_update_posted_date": "2026-09-01", "last_synced_at": "2026-10-12T15:50:00.955Z", "location_count": 3, "location_summary": "Miami, Florida • Kansas City, Missouri • Houston, Texas", "locations": [ { "city": "Miami", "state": "Florida" }, { "city": "Kansas City", "state": "Missouri" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07426419" }, { "nct_id": "NCT04045496", "title": "A First-in-Human, Phase 1 Study of JAB-3312 in Adult Patients With Advanced Solid Tumors", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Non-small Cell Lung Cancer", "Colorectal Cancer", "Pancreatic Ductal Carcinoma", "Esophageal Squamous Cell Carcinoma", "Head and Neck Squamous Cell Carcinoma", "Breast Cancer", "Other Solid Tumors" ], "interventions": [ { "name": "JAB-3312", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Jacobio Pharmaceuticals Co., Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 40, "start_date": "2019-09-26", "completion_date": "2022-12-16", "has_results": false, "last_update_posted_date": "2025-12-29", "last_synced_at": "2026-10-12T15:50:00.955Z", "location_count": 4, "location_summary": "Denver, Colorado • Nashville, Tennessee • Houston, Texas + 1 more", "locations": [ { "city": "Denver", "state": "Colorado" }, { "city": "Nashville", "state": "Tennessee" }, { "city": "Houston", "state": "Texas" }, { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT04045496" }, { "nct_id": "NCT05853705", "title": "Strong Hearts: A Remote, App-Enabled, Exercise Program for Patients With Congenital Heart Disease (Strong Hearts App)", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Congenital Heart Disease" ], "interventions": [ { "name": "Strong Hearts Exercise Program", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Duke University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "10 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "10 Years to 50 Years" }, "enrollment_count": 9, "start_date": "2024-01-12", "completion_date": "2024-12-05", "has_results": false, "last_update_posted_date": "2026-08-05", "last_synced_at": "2026-10-12T15:50:00.955Z", "location_count": 1, "location_summary": "Durham, North Carolina", "locations": [ { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT05853705" }, { "nct_id": "NCT06932081", "title": "Adult Congenital Heart Disease International EValuation of the Effectiveness of SGLT2i Registry", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Adult Congenital Heart Disease", "Congenital Heart Disease", "Systemic Right Ventricle", "Transposition of the Great Arteries", "Congenitally Corrected Transposition of the Great Arteries", "Fontan", "Single Ventricle", "Tetralogy of Fallot (TOF)" ], "interventions": [ { "name": "SGLT2 inhibitors", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Leiden University Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 400, "start_date": "2023-01-01", "completion_date": "2027-12-31", "has_results": false, "last_update_posted_date": "2026-02-13", "last_synced_at": "2026-10-12T15:50:00.955Z", "location_count": 3, "location_summary": "Baltimore, Maryland • Grand Rapids, Michigan • New York, New York", "locations": [ { "city": "Baltimore", "state": "Maryland" }, { "city": "Grand Rapids", "state": "Michigan" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT06932081" }, { "nct_id": "NCT02300558", "title": "Effect of Eleclazine on Shortening of the QT Interval, Safety, and Tolerability in Adults With Long QT Syndrome Type 3", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Long QT Syndrome Type 3" ], "interventions": [ { "name": "Eleclazine", "type": "DRUG" }, { "name": "Eleclazine placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Gilead Sciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 41, "start_date": "2014-12-17", "completion_date": "2017-02-15", "has_results": true, "last_update_posted_date": "2018-01-12", "last_synced_at": "2026-10-12T15:50:00.955Z", "location_count": 3, "location_summary": "Rochester, Minnesota • New York, New York • Rochester, New York", "locations": [ { "city": "Rochester", "state": "Minnesota" }, { "city": "New York", "state": "New York" }, { "city": "Rochester", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02300558" } ] }